Position in NUVL
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$5,393,245
New position
Shares Held
43,670
first reported quarter
Ownership
0.055%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#5
of 35 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026CREDIT INDUSTRIEL ET COMMERCIAL holds $25,265,040 across 7 Biotechnology names. NUVL ranks #3 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
63,424 | $8,418,267 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
193,503 | $6,081,799 | |
| 3 | NUVL |
Nuvalent, Inc.
This page
|
43,670 | $5,393,245 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
33,013 | $1,889,003 | |
| 5 | XOMA |
XOMA Royalty Corp
|
34,853 | $1,481,252 | |
| 6 | RNA |
Atrium Therapeutics, Inc.
|
89,723 | $1,206,774 | |
| 7 | MRNA |
Moderna, Inc.
|
11,348 | $794,700 |
All Filings in NUVL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,393,245 | 43,670 | Shares | Defined | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||